Cargando…
Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
BACKGROUND: Renal atrophy is observed in an irradiated kidney. The aim of this study was to determine dose-volume histogram parameters and other factors that predict renal atrophy after 10-fraction stereotactic body radiotherapy (SBRT) for primary renal cell carcinoma (RCC). METHODS: A total of 14 p...
Autores principales: | Yamamoto, Takaya, Kadoya, Noriyuki, Takeda, Ken, Matsushita, Haruo, Umezawa, Rei, Sato, Kiyokazu, Kubozono, Masaki, Ito, Kengo, Ishikawa, Yojiro, Kozumi, Maiko, Takahashi, Noriyoshi, Katagiri, Yu, Onishi, Hiroshi, Jingu, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881181/ https://www.ncbi.nlm.nih.gov/pubmed/27229710 http://dx.doi.org/10.1186/s13014-016-0651-5 |
Ejemplares similares
-
Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015) -
Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A
Review
por: Matsushita, Haruo, et al.
Publicado: (2018) -
Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Jingu, Keiichi, et al.
Publicado: (2018) -
Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy
por: Yamamoto, Takaya, et al.
Publicado: (2020) -
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016)